# EGFR Bioactivity Prediction - Project Summary

## 🎯 Executive Summary

Built an ensemble machine learning model to predict EGFR inhibitor bioactivity with **94.54% ROC-AUC**, validated on FDA-approved drugs with 100% accuracy, and deployed as an interactive Streamlit web application.

## 📊 Key Achievements

- ✅ Collected and processed 20,033 compounds from ChEMBL
- ✅ Engineered 12 molecular descriptors using RDKit
- ✅ Trained 4 models: RF, XGBoost, Neural Network, Ensemble
- ✅ Achieved 94.54% ROC-AUC (publication-quality)
- ✅ 100% validation accuracy on 8 known drugs
- ✅ Deployed production-ready Streamlit application

## 🏆 Model Performance

**Best Model:** Weighted Ensemble (70% RF + 15% XGB + 15% NN)
- ROC-AUC: 0.9454
- Accuracy: 92.94%
- Precision: 95.56%
- Recall: 96.03%

## 💼 Skills Demonstrated

### Technical Skills
- Python programming (pandas, numpy, scikit-learn)
- Cheminformatics (RDKit molecular descriptors)
- Machine learning (ensemble methods, neural networks)
- Model evaluation (ROC-AUC, cross-validation)
- Web deployment (Streamlit)

### Domain Knowledge
- Drug discovery pipeline understanding
- EGFR cancer biology
- Structure-activity relationships (SAR)
- Lipinski's Rule of Five (drug-likeness)

### Software Engineering
- Clean code architecture
- Model serialization and deployment
- Version control (Git)
- Documentation

## 📈 Business Impact

**Value Proposition:**
- Reduces experimental screening costs by computationally filtering compounds
- Accelerates drug discovery timeline from years to months
- Enables virtual screening of millions of compounds
- Industry relevance: AI drug discovery market projected $14.2B by 2032

## 🎤 Interview Talking Points

1. **"Walk me through your project"**
   - Collected 25K compounds → Calculated descriptors → Trained ensemble → Validated on FDA drugs → Deployed web app

2. **"What challenges did you face?"**
   - Class imbalance (7:1 ratio) → Solved with SMOTE
   - RDKit descriptor calculation → Fixed FractionCsp3 import issue
   - Deployment → Used Streamlit for internal tool standard

3. **"What would you improve?"**
   - Add Morgan fingerprints for richer features
   - Multi-task learning for multiple cancer targets
   - SHAP values for explainable AI
   - Deploy to cloud (AWS/Streamlit Cloud)

4. **"How does this relate to bioinformatics?"**
   - Similar to genomics pipelines (data → features → ML → insights)
   - ChEMBL API like NCBI/EBI databases
   - Transferable to protein-ligand binding prediction

## 📝 Resume Bullets
```
- Developed ensemble ML pipeline (Random Forest, XGBoost, Neural Network) to predict 
  EGFR inhibitor bioactivity using 20,033 compounds from ChEMBL database, achieving 
  94.54% ROC-AUC with 100% validation accuracy on FDA-approved drugs

- Engineered 12 molecular descriptors using RDKit cheminformatics library and applied 
  SMOTE oversampling to handle 7:1 class imbalance, improving model generalization

- Deployed interactive Streamlit web application with single and batch prediction 
  capabilities, demonstrating production-ready ML deployment skills
```

## 🎓 Learning Outcomes

- ✅ End-to-end ML project experience
- ✅ Cheminformatics expertise (RDKit)
- ✅ Ensemble learning techniques
- ✅ Model validation best practices
- ✅ Web application deployment
- ✅ Pharmaceutical domain knowledge

## 📅 Timeline

**6-Day Sprint:**
- Day 1: Data collection (ChEMBL API)
- Day 2: Preprocessing & descriptors
- Day 3: Model training & optimization
- Day 4: Validation with known drugs
- Day 5: Streamlit deployment
- Day 6: Documentation & finalization

---

**Created by Vedant Kulkarni | Northeastern University | Bioinformatics MS**
